Showing 1461-1470 of 2314 results for "".
- Ocuphire Appoints Jay Pepose, MD, PhD, as Chief Medical Advisor and Announces Upcoming Presentations at ASCRS 2022 and Eyeceleratorhttps://modernod.com/news/ocuphire-appoints-jay-pepose-md-phd-as-chief-medical-advisor-and-announces-upcoming-presentations-at-ascrs-2022-and-eyecelerator/2480777/Ocuphire Pharma announced the appointment of Jay Pepose, MD, PhD, as its Chief Medical Advisor. In addition, Dr. Pepose, Dr. Ralph Chu, and Dr. Marguerite McDonald will deliver three presentations on Nyxol at the American Society of Cataract and Refractive Surgery (ASCRS) which will
- AbbVie Appoints Robert A. Michael as Chief Executive Officerhttps://modernod.com/news/abbvie-appoints-robert-a-michael-as-chief-executive-officer/2482125/AbbVie, the parent company of Allergan, announced that its board of directors has unanimously selected Robert A. Michael, AbbVie's current president and chief operating officer, to succeed Richard A. Gonzalez as the company's chief executive officer (CEO). Mr. Gonzalez
- ViaLase Makes Several Appointments to its Executive Teamhttps://modernod.com/news/vialase-makes-several-appointments-to-its-executive-team/2481244/ViaLase announced the appointments of Tom Frinzi as Executive Chairman of the Board; Richard Lewis, MD, as Chief Medical Officer; Shawn O'Neil as Chief Commercial Officer; and Brendan O'Herlihy as Vice President, Global Commercial Operations. The executives w
- American Academy of Optometry Launches Nationwide Search for New CEOhttps://modernod.com/news/american-academy-of-optometry-launches-nationwide-search-for-new-ceo/2480968/The American Academy of Optometry (AAO) has formed a search committee to identify candidates for the position of Chief Executive Officer. Current Chief Financial Officer (CFO)/Deputy CEO Richard Jones will serve as Interim Chief Executive Officer throughout the search. Mr. Jones has more than 20
- Poll: Medicare Advantage Members Are Taking to Telehealthhttps://modernod.com/news/poll-medicare-advantage-members-are-taking-to-telehealth/2477831/A new poll found that roughly half of seniors are comfortable using telehealth to get healthcare, and those that do largely say they had a favorable experience, according to a FierceHealthcare
- FDA, CDC Say No Need for COVID-19 Booster Vaccines in US At This Timehttps://modernod.com/news/fda-cdc-say-no-need-for-covid-19-booster-vaccines-in-us-at-this-time/2479358/The FDA and the US Centers for Disease Control and Prevention (CDC) said that people who have been fully immunized against COVID-19 do not require a booster vaccine at this time, according to a FirstWord report. The jo
- Trump Health Official Says COVID Patients Should Not Re-Test. ‘It’s clogging up the system.’https://modernod.com/news/trump-health-official-says-covid-patients-should-not-re-test-its-clogging-up-the-system/2478038/The Trump administration plans to release guidance that non-hospitalized patients who test positive for COVID-19 do not need a second test to confirm they are clear of the virus, according to a FierceHealthcare
- AMA Pushes for Federal Intervention to Reform Prior Authorizationhttps://modernod.com/news/ama-pushes-for-federal-intervention-to-reform-prior-authorization/2477934/Docs say health plans have made little progress toward streamlining prior authorization—despite pledging to do so 2 years ago, according to a FierceHealthcare report.
- WHO Launches First World Report on Visionhttps://modernod.com/news/who-launches-first-world-report-on-vision/2476958/More than 1 billion people worldwide are living with vision impairment because they do not get the care they need for conditions like short and farsightedness, glaucoma, and cataract, according to the first World report on v
- Results RNA Issues Voluntary Worldwide Recall of Lubrisine Eye Drops Due to Manufacturing Sterility Concerns and Undeclared Colloidal Silverhttps://modernod.com/news/results-rna-issues-voluntary-worldwide-recall-of-lubrisine-eye-drops-due-to-manufacturing-sterility-concerns-and-undeclared-colloidal-silver/2476230/Results RNA is voluntarily recalling Lubrisine Eye Drops to the healthcare practitioner, retail or consumer level. This product, in a recent FDA inspection, was found to be manufactured using practices that do not support its sterility and contained undeclared colloidal silver.